E-LIB Suche - Ergebnisse für: Ahn, Inhye E. - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

B-cell receptor pathway mutations are infrequent in patient..:

Woyach, Jennifer A ; Ghia, Paolo ; Byrd, John C...
info:eu-repo/semantics/altIdentifier/pmid/37314786. , 2023

Link: https://hdl.handle.net/2..

2

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritama..:

Mhibik, Maissa ; Gaglione, Erika M ; Eik, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388733/. , 2023

Link: http://www.ncbi.nlm.nih...

3

B-cell Receptor Pathway Mutations Are Infrequent in Patient..:

Woyach, Jennifer A ; Ghia, Paolo ; Byrd, John C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425728/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Characteristics and Clinical Outcomes of Patients with Chro..:

Woyach, Jennifer A ; Barr, Paul M ; Kipps, Thomas J...
qt27b651p6. , 2023

Link: https://escholarship.org..

5

Interim Positron Emission Tomography During Frontline Chemo..:

Merryman, Reid W ; Michaud, Laure ; Redd, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875968/. , 2023

Link: http://www.ncbi.nlm.nih...

6

BTK inhibitors impair humoral and cellular responses to rec..:

Pleyer, Christopher ; Laing, Kerry J ; Ali, Mir A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941484/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Selecting initial therapy in CLL:

Ahn, Inhye E ; Brown, Jennifer R
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820765/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Long‐term efficacy of first‐line ibrutinib treatment for ch..:

Allan, John N ; Shanafelt, Tait ; Wiestner, Adrian...
qt6f10v81j. , 2022

Link: https://escholarship.org..

9

Long‐term efficacy of first‐line ibrutinib treatment for ch..:

Allan, John N ; Shanafelt, Tait ; Wiestner, Adrian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299890/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Effect of Bruton tyrosine kinase inhibitor on efficacy of a..:

Pleyer, Christopher ; Ali, Mir A ; Cohen, Jeffrey I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820878/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Clinical Outcomes in Patients with Multi-Hit TP53 Chronic L..:

Brieghel, Christian ; Aarup, Kathrine ; Torp, Mathias H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364879/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Targeting Bruton's Tyrosine Kinase in CLL:

Ahn, Inhye E ; Brown, Jennifer R
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261291/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Prediction of Outcome in Patients With Chronic Lymphocytic ..:

Ahn, Inhye E ; Tian, Xin ; Ipe, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189626/. , 2021

Link: http://www.ncbi.nlm.nih...

14

BTK inhibitors, irrespective of ITK inhibition, increase ef..:

Mhibik, Maissa ; Gaglione, Erika M ; Eik, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586964/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Select antitumor cytotoxic CD8(+) T clonotypes expand in pa..:

Baptista, Maria Joao ; Baskar, Sivasubramanian ; Gaglione, Erika M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364883/. , 2021

Link: http://www.ncbi.nlm.nih...

1-15